[ Price : $8.95]
A Sidley law briefing examines HHSs unprecedented overreach during the Trump Administration, which has drawn increased interest in...[ Price : $8.95]
FDA approves an Exelixis NDA for Cabometyx (cabozantinib) in combination with Bristol Myers-Squibbs Opdivo (nivolumab) for treatin...[ Price : $8.95]
FDA gives the green light to Ultragenyx Pharmaceutical to begin a seamless single-protocol Phase 1/2/3 study of UX701, an investig...[ Price : $8.95]
NJ attorney general Gurbir S. Grewal announces a $5 million settlement with Insys Therapeutics founder John N. Kapoor to resolve a...[ Price : $8.95]
The Medical Device Innovation Consortium says it will receive comments for the next month on its External Evidence Methods Framewo...[ Price : $8.95]
FDA issues a guidance to give manufacturers of licensed and investigational cellular and gene therapy products risk-based recommen...[ Price : $8.95]
FDA accepts for priority review a Genentech supplemental NDA for Esbriet (pirfenidone) for treating unclassifiable interstitial lu...